Beyond transfusion: Platelet‐derived therapeutic products as a new frontier for blood establishments and transfusion medicine
Platelet-derived products represent a new frontier for transfusion medicine, enabling value creation from surplus PCs. Ethical development, standardized production and stepwise clinical evaluation are essential to realize their promise in regenerative and precision medicine.
Authors
- Thierry Pierre Robert Burnouf (ORCID: https://orcid.org/0000-0002-0507-9243)
- Paul Strengers (ORCID: https://orcid.org/0000-0002-5496-8872)
- Michael Paul Busch (ORCID: https://orcid.org/0000-0002-1446-125X)
Institutions
- University of California, San Francisco (US)
- Pacific Research Institute (US)
- Dutch Blood Transfusion Society (NL)
- Vitalant (US)
- Taipei Medical University-Shuang Ho Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Vox Sanguinis
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1111/vox.70155
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.00